Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:RVLP

RVL Pharmaceuticals (RVLP) Stock Price, News & Analysis

RVL Pharmaceuticals logo

About RVL Pharmaceuticals Stock (NASDAQ:RVLP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.00
$0.19
52-Week Range
N/A
Volume
63.96 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RVLP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RVL Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RVLP Stock News Headlines

Raval ICS Ltd.
REVEALED: Something Big Happening Behind White House Doors
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for yourself. Once you see what’s unfolding behind the scenes, you’ll understand why I rushed this interview and opportunity to you today.tc pixel
RVLPQ RVL Pharmaceuticals plc
RVL Pharmaceuticals PLC RVLPQ
See More Headlines

RVLP Stock Analysis - Frequently Asked Questions

RVL Pharmaceuticals PLC (NASDAQ:RVLP) announced its quarterly earnings data on Monday, March, 20th. The company reported ($0.18) EPS for the quarter, missing the consensus estimate of ($0.15) by $0.03. The firm had revenue of $9.81 million for the quarter, compared to analysts' expectations of $12.10 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that RVL Pharmaceuticals investors own include Avino Silver & Gold Mines (ASM), Cardiff Oncology (CRDF), Osmotica Pharmaceuticals (OSMT), AbCellera Biologics (ABCL), Amarin (AMRN), Coda Octopus Group (CODA) and Fission Uranium (FCUUF).

Company Calendar

Last Earnings
3/20/2023
Today
9/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
N/A
Current Symbol
NASDAQ:RVLP
CIK
1739426
Fax
N/A
Employees
125
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$49.72 million
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:RVLP) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners